Modulation of osteogenic differentiation in human skeletal cells in Vitro by 5-azacytidine.

Modulation of osteogenic differentiation in human skeletal cells in Vitro by 5-azacytidine.

Cellular differentiation is controlled by a variety of factors including gene methylation, which represses particular genes as cell fate is determined. The incorporation of 5-azacytidine (5azaC) into DNA in vitro prevents methylation and thus can alter cellular differentiation pathways. Human bone m...

Descripció completa

Dades bibliogràfiques
Autors principals:	Locklin, R, Oreffo, R, Triffitt, J
Format:	Journal article
Idioma:	English
Publicat:	1998

Ítems similars

Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
per: Xia, Z, et al.
Publicat: (2008)

In vitro and in vivo methods to determine the interactions of osteogenic cells with biomaterials.
per: Oreffo, R, et al.
Publicat: (1999)

Effects of TGFbeta and bFGF on the differentiation of human bone marrow stromal fibroblasts.
per: Locklin, R, et al.
Publicat: (1999)

Genetic labelling of osteogenic cells.
per: Smith, L, et al.
Publicat: (1997)

Expression of BMP-2 and BMP-4 during osteogenic differentiation of human marrow stromal fibroblasts
per: Triffitt, J, et al.
Publicat: (1999)

Future potentials for using osteogenic stem cells and biomaterials in orthopedics.
per: Oreffo, R, et al.
Publicat: (1999)

Skeletal progenitor cells and ageing human populations.
per: Oreffo, R, et al.
Publicat: (1998)

Retroviral marking of human bone marrow fibroblasts: In vitro expansion and Homing to skeletal sites in vivo.
per: Oreffo, R, et al.
Publicat: (1999)

Osteogenic stem-cell characterization and development: potentials for cytotherapy.
per: Triffitt, J, et al.
Publicat: (2001)

Effects of EZH2 inhibitor, trichostatin A, and 5-azacytidine combinatorial treatment on osteogenic differentiation of dental pulp stem cells
per: Edit Hrubi, et al.
Publicat: (2024-06-01)

Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro.
per: Oreffo, R, et al.
Publicat: (1999)

Modulation of human osteoprogenitor cell differentiation by 9-CIS retinoic acid and retinoic acid
per: Oreffo, R, et al.
Publicat: (1997)

Effects of beta mercaptoethanol on the proliferation and differentiation of human osteoprogenitor cells.
per: Inui, K, et al.
Publicat: (1997)

The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro.
per: Beresford, J, et al.
Publicat: (1994)

Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors.
per: Oreffo, R, et al.
Publicat: (1998)

5-azacytidine for beta-thalassemia?
per: Clegg, J, et al.
Publicat: (1983)

Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.
per: Teruyo Oishi, et al.
Publicat: (2013-01-01)

EFFECTS OF BETA-MERCAPTOETHANOL AND ASCORBATE ON THE PROLIFERATION AND DIFFERENTIATION OF HUMAN BONE-MARROW STROMAL FIBROBLASTIC CELLS
per: Inui, K, et al.
Publicat: (1995)

Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures.
per: Oreffo, R, et al.
Publicat: (1997)

Synthesis and Antiproliferative Activities of 5-Azacytidine Analogues in Human Leukemia Cells
per: Lin-Xiang Zhao, et al.
Publicat: (2008-07-01)

Interconversion potential of cloned human marrow adipocytes in vitro.
per: Park, SR, et al.
Publicat: (1999)

ANALYSIS OF THE IN VIVO FREQUENCY AND THE IN VITRO OSTEOGENIC DIFFERENTIATION OF IMMUNOPHENOTIPICALLY DEFINED HUMAN SKELETAL STEM AND PROGENITOR CELL SUBPOPULATIONS
per: IS Costa, et al.
Publicat: (2023-10-01)

Effects of interferon alpha on human osteoprogenitor cell growth and differentiation.
per: Oreffo, R, et al.
Publicat: (1997)

Development of specific collagen scaffolds to support the osteogenic and chondrogenic differentiation of human bone marrow stromal cells.
per: Dawson, J, et al.
Publicat: (2008)

5-Azacytidine-Induced Cardiomyocyte Differentiation of Very Small Embryonic-Like Stem Cells
per: XiaoLin Sun, et al.
Publicat: (2020-01-01)

Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36
per: Joubert-Caron Raymonde, et al.
Publicat: (2001-12-01)

Human bone marrow osteoprogenitors express estrogen receptor mRNA during osteoblastic differentiation in vitro
per: Oreffo, R, et al.
Publicat: (1996)

Inhibition of adipogenesis and modulation of human bone marrow osteoprogenitor differentiation by 9-cis retinoic acid and retinoic acid.
per: Oreffo, R, et al.
Publicat: (1997)

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
per: Xu N, et al.
Publicat: (2021-04-01)

Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells.
per: Xia, Z, et al.
Publicat: (2005)

Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo.
per: Oreffo, R, et al.
Publicat: (2001)

Osteoblast stem cell number and human aging.
per: Oreffo, R, et al.
Publicat: (1996)

In vitro effects of growth factors and dexamethasone on rat marrow stromal cells.
per: Locklin, R, et al.
Publicat: (1995)

Genetic labelling of human bone marrow osteogenic stem cells: Differentiation potentials and engraftment into NOD/SCID mice.
per: Xia, Z, et al.
Publicat: (2001)

Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements.
per: Oreffo, R, et al.
Publicat: (1998)

Enhanced in Vitro Anti-Tumor Activity of 5-Azacytidine by Entrapment into Solid Lipid Nanoparticles
per: Farhad Jahanfar, et al.
Publicat: (2016-09-01)

Long non-coding RNA levels can be modulated by 5-azacytidine in Schistosoma mansoni
per: Murilo S. Amaral, et al.
Publicat: (2020-12-01)

Osteogenic stem cells and orthopedic engineering: summary and update.
per: Triffitt, J
Publicat: (2002)

Human mesenchymal stem cell numbers do not decrease with age
per: Oreffo, R, et al.
Publicat: (1996)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
per: Panagiotis Diamantopoulos, et al.
Publicat: (2019-05-01)